Physician profile
Alan D Chap
NPI 1144481490
$656.94
in general payments reported to CMS, 2019-2025
9 companies · $59.89 in 2025
The $59.89 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2021: $334 · 2022: $133 · 2023: $20.32 · 2025: $59.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $46.21 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $46.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $150.00 | 2021 | |
| Haemonetics Corporation | $111.85 | 2022 | |
| Genentech USA, INC. | $108.93 | 2019 | |
| Abiomed | $105.18 | 2021 | |
| Karl Storz Endoscopy-America | $79.14 | 2021 | |
| Becton, Dickinson and Company | $34.00 | 2025 | Introducer Needle |
| Humacyte Global, INC. | $25.89 | 2025 | Symvess |
| Ethicon US, LLC | $21.63 | 2022 | |
| Baxter Healthcare | $20.32 | 2023 | Renal - Acute |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Chap listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.